Inflammation of seborrheic keratoses caused by cytarabine: a pseudo sign of Leser-Trelat.
Cytarabine, used for the treatment of acute myelogenous leukemia, can cause a rare reaction of inflammation of existing seborrheic keratoses. We report a case of cytarabine induced inflammation of seborrheic keratoses mimicking a vesicular eruption in 53-year-old man with acute myelogenous leukemia.
Patton
Timothy
T
Department of Dermatology University of Pittsburgh, Pittsburgh, Pennsylvania, USA. pattontj@msx.upmc.edu
Zirwas
Matthew
M
Nieland-Fisher
Nancy
N
Jukic
Drazen
D
D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D003561:Cytarabine / Q000009:adverse effects*; D006801:Humans; D007249:Inflammation / Q000139:chemically induced*; D017492:Keratosis, Seborrheic / Q000139:chemically induced* / Q000473:pathology; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy; D008297:Male; D008875:Middle Aged
D000964:Antimetabolites, Antineoplastic; D003561:Cytarabine